SF1729

This bill, Minnesota Senate File No. 1729, proposes modifications to the state's regulations on hemp-derived cannabinoid products, particularly edible and topical products. Key provisions in the bill include:

1. Sales Regulations for Cannabinoid Products

   • Permits the sale of nonintoxicating cannabinoid products (including edible cannabinoid products) for human or animal consumption, provided they meet legislative requirements.
     
   • Ensures THC limits are maintained at no more than 0.3% total THC, with further restrictions on edible product potency.
     
   • Clarifies that certain topical cannabinoid products can be sold but must not be designed for inhalation, ingestion, or injection.
     

2. Restrictions on Medical or Structural Claims

   • Prohibits sales of hemp-derived cannabinoids if they are marketed as treating, curing, or preventing diseases or affecting body structure/function, aligning with FDA guidelines.
     

3. Age Restrictions

   • Prohibits the sale of any cannabinoid or THC product to individuals under 21.
     

4. Onsite Consumption Rules

   • Allows on-premises consumption in licensed establishments (with an appropriate alcohol license), but with restrictions:
     
     • Products must remain in their original packaging unless consumed on-site.
       
     • Retailers must not sell to intoxicated consumers.
       
     • Cannabinoid products cannot be mixed with alcoholic beverages and must not be removed from the premises if unsealed.
       

5. Licensing and Compliance for Manufacturers

   • Permits vendors selling edible cannabinoids to convert their registration into a hemp license.
     
   • Requires hemp edible manufacturers to comply with fire, zoning, and sanitation regulations to ensure clean and pest-free facilities.
     

6. Labeling Requirements for Hemp Topicals

   • Mandates specific labeling information, including:
     
     • Manufacturer details
       
     • Cannabinoid content (CBD, CBG, etc.)
       
     • Testing lab information
       
     • Disclaimer that the product is not FDA-approved or intended to treat diseases
       

7. Prohibitions on Unsafe or Contaminated Products

   • Bans products that:
     
     • Contain decomposed or contaminated ingredients.
       
     • Are produced in unsanitary conditions.
       
     • Have unsafe FDA-banned additives.
       
     • Contain inaccurate cannabinoid content per the label.
       
     • Have unauthorized cannabinoids exceeding permissible limits.
       
   • Requires compliance with state testing standards.
     

Summary

This bill updates Minnesota’s hemp and cannabinoid product regulations, imposing new licensing, sales, labeling, and safety requirements while tightening rules on marketing, age restrictions, and on-site consumption. It aims to ensure product safety, prevent misleading health claims, and establish clearer rules for businesses selling hemp-derived cannabinoids.

Would you like a more detailed explanation on any section?